Prot# EFC4529: Comparison of Efficacy and Safety of Zolpidem-MR 12.5mg and Placebo in Patients with Primary Insomnia. A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study.

Project: Research project

Project Details

StatusFinished
Effective start/end date7/18/02 → 7/18/08

Funding

  • Sanofi-Synthelabo Inc. (EFC4529)